Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small integral membrane protein 23 (SMIM23) is a protein-coding gene located on human chromosome 5 (gene symbol: SMIM23, previously C5orf50), encoding a protein with a predicted transmembrane domain[1][3][5][8]. The gene is composed of four exons and is expressed mainly in the testes, though expression data are limited[1][2]. Its structure consists of alpha-helical regions typical of membrane proteins, but its exact cellular localization (membrane versus cytosolic) is not fully resolved[1]. Some studies suggest it may play a role in the morphological development of facial features—particularly in people of European descent—and possibly in determining human height, though its precise cellular function remains unknown[1][2]. SMIM23 is not currently recognized as a therapeutic target, and there are no drugs known to interact with it[1][3][8]. It is evolutionarily conserved among mammals, and bioinformatics analyses indicate possible interactions with proteins involved in cellular structure and DNA repair, but there is no evidence for direct involvement in major signaling pathways or disease mechanisms[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small integral membrane protein 23 (SMIM23).